SPHK1 and triple-negative breast carcinoma: Studies have reported that SPHK1 expression is increasing in trend along with the advancement of breast tumor staging; while basal-like triple negative breast cancer (TNBC) tumors exhibit the highest levels of SPHK1 when compared to other subtypes.